Citicholine.
Research-backed compound with potential health benefits. Gives your brain two key things: choline (for the memory neurotransmitter acetylcholine) and cytidine (which helps build and repair brain cell membranes).
Reviewed March 2026
- Category
- Compound
What Citicholine is, and what it does.
- Does it work
- Yes. It’s not a magic genius pill, but the evidence for supporting focus, memory, and long-term brain health is respectable. A worthwhile investment.
- How much to take
- 500-1000mg per day. It’s best to split the dose, like 250mg in the morning and 250mg in the early afternoon.
- Time to feel it
- Give it two to four weeks. The attention and recall measures used in trials shift across that window rather than after a single serving.
- The first dose
- Nothing. Seriously. It's not a stimulant. It needs time to build up in your system.
- With regular use
- After a few weeks, expect clearer thinking and better focus. The effect is gradual – you might not notice it until you stop taking it.
- How well tolerated
- Well tolerated. One of the most well-tolerated nootropics. Extensive human studies show a low risk of side effects at standard doses.
- How it feels
- It doesn't 'feel' like anything. No buzz, no rush. It works quietly in the background to make your brain run more efficiently.
- The overlooked benefit
- In people, the cytidine half is mostly converted to uridine, which feeds the same membrane-building cycle. That's why citicoline and uridine keep turning up together.
250 to 500mg a day is where Citicholine works.
Source: Cochrane Database Syst Rev. 2005;(2):CD000269. Citicoline cognitive review.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Citicholine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Attention and focus measures in healthy adultsRandomised trial
- Memory measures in older adultsRandomised trial
- Mental processing speedRandomised trial
- Choline supply for acetylcholine synthesisNarrative review
- Phosphatidylcholine membrane synthesis through the Kennedy pathwayNarrative review
Questions people ask about Citicholine.
- Is this a stimulant like Adderall or caffeine?
- Nope. It's a nutrient for your brain, not a stimulant. No jitters, no crash. It builds brain health over time.
- What's the difference between Citicholine and Alpha-GPC?
- Both supply choline. Citicholine also gives you cytidine, which helps repair brain cells. Some people respond better to one over the other.
- Can I take it with my morning coffee?
- Yes. They stack well. Coffee gives you the immediate wake-up call, while citicholine provides the long-term structural support.
- Is it better to take it with food?
- Doesn't really matter. Take it whenever is most convenient for you to be consistent.
- Will this help me cram for an exam?
- Not really. It’s for long-term memory and focus support, not an all-nighter boost. Think marathon, not a sprint.
- Is this the same as choline from eggs?
- It's a more direct and bioavailable form. Your body has to convert choline from food, but citicholine is already a step ahead in the process.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Citicoline donates cytidine diphosphocholine, the head-group carrier in the Kennedy pathway, while DHA supplies the fatty acid tail esterified into the same phosphatidylcholine. Both substrates present means more finished membrane phospholipid than either alone.
Phosphatidylserine is formed by base exchange from phosphatidylcholine and phosphatidylethanolamine, the pools citicoline feeds. Supplying the precursor and the finished phospholipid supports neuronal membrane turnover from two points.
Citicoline raises the choline available for acetylcholine synthesis and huperzine A slows acetylcholinesterase, the enzyme that breaks acetylcholine down. One fills the pool and the other slows its drain.
Acetylcholine is made by choline acetyltransferase from choline and acetyl-CoA, and coenzyme A is built from pantothenate. Choline supply without acetyl-CoA supply leaves the reaction half-fed.
Racetams raise cholinergic turnover, and a choline donor is paired with them to meet that demand. Citicoline is the donor most often used for that role.
Both deliver choline, citicoline as the cytidine-bearing intermediate and alpha-GPC as the glycerophospho form that also feeds membrane lipid. Stacking them raises total choline load, so the combined amount should be counted once.
Caffeine acts on adenosine receptors and citicoline on cholinergic supply and membrane phospholipid, so the two do not share a target. Attention formulas pair them for that non-overlapping reason.
Choline and the folate and B12 methyl cycle both feed the SAM pool, and choline is spared when remethylation from B12 and folate is adequate. Supplying both sides keeps phosphatidylcholine synthesis from drawing down methyl groups.
Betaine is the oxidised form of choline and donates a methyl group to remethylate homocysteine. Supplying betaine spares choline for acetylcholine and phospholipid use rather than methyl donation.
Oral citicoline is broken down in the gut wall to free choline and cytidine, both of which are absorbed and then reassembled into CDP-choline inside cells. Supplemental choline feeds the same pool from the other direction. Combining them means counting total choline intake rather than counting two separate ingredients.
In the Kennedy pathway, choline is phosphorylated to phosphocholine, activated to CDP-choline, and then transferred onto diacylglycerol to form phosphatidylcholine. Citicoline supplies the intermediate; phosphatidylcholine is the product. Supplying both puts material into the same pathway at two points.
Humans convert circulating cytidine largely to uridine, which is then salvaged back to UTP and on to CTP, the activated nucleotide that drives CDP-choline formation. Uridine monophosphate feeds that same pyrimidine pool directly. The two routes converge, which is why the pairing appears in formulas built around membrane phospholipid synthesis.
The two committed steps of the Kennedy pathway use ATP and CTP, and both nucleotides are handled by their enzymes as magnesium complexes. Magnesium is therefore required for the pathway to run at all. This is a cofactor relationship rather than a reason to expect an added effect at adequate magnesium status.
Citicoline supplies the head group for phosphatidylcholine while long-chain omega-3 fatty acids supply the acyl chains that end up in the membrane. Both halves are needed to build the finished phospholipid. The corpus already stores DHA as a partner here; EPA enters the same acyl pool through retroconversion and elongation steps.
In mammalian cells, phosphatidylserine synthase 1 swaps the choline head group of phosphatidylcholine for serine. Citicoline raises the supply of the phosphatidylcholine substrate and serine supplies the incoming head group. This is textbook membrane biochemistry, not a measured clinical pairing.
Choline can be oxidised to betaine, which remethylates homocysteine to methionine through betaine homocysteine methyltransferase, running in parallel with the folate-dependent methionine synthase route. Low folate raises demand on the choline route and the same is true in the other direction. Citicoline feeds the choline pool that supplies that alternative path.
Homocysteine leaves the methylation cycle either by remethylation, which choline supports through betaine, or by transsulfuration, which requires vitamin B6 as pyridoxal 5-phosphate. The two exits work in parallel. Citicoline contributes to the remethylation side by way of the choline pool.
Besides the Kennedy pathway, the liver makes phosphatidylcholine by methylating phosphatidylethanolamine three times using S-adenosylmethionine. That route consumes a substantial share of the body's methyl groups. Citicoline supports the other route, which is the one that does not spend methyl donors.
Choline is irreversibly oxidised to betaine in liver and kidney mitochondria, and betaine then donates a methyl group to homocysteine. Supplying betaine directly spares choline for the phospholipid and acetylcholine routes instead. The corpus already stores this pairing under an alternative name for the same molecule.
Acetyl-L-carnitine carries an acetyl group across the mitochondrial membrane and can contribute to the cytosolic acetyl-CoA pool, while citicoline supplies choline. Choline acetyltransferase needs both an acetyl donor and choline. The pairing is common in cognitive formulas and rests on the shared reaction rather than on combination trials.
Bacopa is one of the more frequently studied botanicals for memory endpoints and is a conventional partner to choline donors in nootropic blends. The two act on different substrates and no combination trial links them. Regard the pairing as formulation convention.
Lion's mane is routinely blended with choline donors in cognitive products. Its studied constituents act through nerve growth factor signalling rather than through phospholipid supply, so the routes do not overlap. Human data on the mushroom remains small and short.
L-theanine is structurally close to glutamate and is associated with increased alpha wave activity and reduced subjective jitter. It is commonly stacked with the caffeine already recorded as a partner here. The interaction is with the stimulant component of a blend rather than with citicoline directly.
Choline kinase phosphorylates choline using ATP, and the creatine phosphate system buffers cytosolic ATP concentration in tissues with high and variable demand. Better ATP buffering supports any ATP-dependent step. This is a general bioenergetic argument, not evidence that creatine increases phosphatidylcholine synthesis.
The mitochondrial oxidation of choline to betaine aldehyde runs through choline dehydrogenase, a flavoprotein that requires FAD derived from riboflavin. Riboflavin is also needed to keep methylenetetrahydrofolate reductase working in the parallel folate route. Both are cofactor relationships from textbook biochemistry.
Ginkgo appears with choline donors in a large share of cognitive blends and has its own separate human literature. The mechanisms proposed for ginkgo concern blood flow and platelet activity rather than phospholipid supply. No combination trial supports the pairing, and ginkgo's platelet effects are worth accounting for separately.
Nothing specific on file for Citicholine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Citicholine actually does.
Citicoline is CDP-choline, the activated middle piece of the Kennedy pathway. That pathway builds phosphatidylcholine in three moves: choline picks up a phosphate, that gets activated into CDP-choline, then the head group is handed onto a fat backbone.
Swallowed citicoline never reaches your blood in one piece. Your intestinal wall splits it into free choline and cytidine, both absorbed separately, and your cells then reassemble CDP-choline from the parts.
In humans, most of the absorbed cytidine gets converted to uridine, which is salvaged to UTP and turned back into CTP. That recycling is why the cytidine half behaves differently in humans and rodents, and why uridine keeps showing up in the same conversation.
The activating enzyme is the slow step for the whole pathway, and it flips on by moving from floating loose in the cell to sitting on a membrane. So membrane fat composition feeds back on how fast phosphatidylcholine gets made.
Where Citicholine comes from.
There are two ways to make it. One uses live yeast or bacteria in a fermentation tank, fed sugar and the building blocks, and lets the cells assemble the molecule the same way your own cells do. The other builds it step by step with chemistry. Either way, the mixture is filtered, separated and crystallised into a white powder, then tested against a reference sample before it goes into capsules. The powder pulls in moisture from the air, so it is packed and handled dry.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
The fermentation route feeds a sugar substrate plus choline chloride and orotic acid to a yeast or bacterial culture. The synthetic route starts from cytidine monophosphate and phosphocholine intermediates.
In fermentation, the organism's own cytidylyltransferase activity joins the activated cytidine nucleotide to phosphocholine inside the cell. In the synthetic route the same bond is formed chemically, usually through an activated phosphate intermediate.
Cells are lysed or the broth is clarified, and the nucleotide is pulled out of the aqueous phase. Chromatographic separation removes closely related nucleotides.
Ion exchange separates the diphosphate species from mono- and triphosphate impurities, and the product is crystallised, commonly as the sodium salt.
Purity is confirmed by chromatography against a reference standard, with limits set on related nucleotides and residual solvent. Labels usually state whether the figure is the salt or the free base.
Supplied as a hygroscopic powder that is blended, encapsulated or compressed. Moisture control during handling matters more here than for most actives.
Getting Citicholine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- The authors report that combining bone marrow cell treatment with neurotransmitters and citicoline was associated with molecular and functional recovery measures in an experimental spinal cord injury model.Animal study. Paulose et al., 2017 (Biomedical Journal). PMID 28521906 ↗
- Nutraceutical compositions including citicoline among their components were tested in an induced neuropathic cell model, with the authors reporting effects on the measured cellular markers.In vitro study. Ferrari et al., 2024 (International Journal of Molecular Sciences). PMID 38397054 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Citicholine. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.